Cargando…
A Peptide Antagonist of the ErbB1 Receptor Inhibits Receptor Activation, Tumor Cell Growth and Migration In Vitro and Xenograft Tumor Growth In Vivo
The epidermal growth factor family of receptor tyrosine kinases (ErbBs) plays essential roles in tumorigenesis and cancer disease progression, and therefore has become an attractive target for structure-based drug design. ErbB receptors are activated by ligand-induced homo- and heterodimerization. S...
Autores principales: | Xu, Ruodan, Povlsen, Gro Klitgaard, Soroka, Vladislav, Bock, Elisabeth, Berezin, Vladimir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619243/ https://www.ncbi.nlm.nih.gov/pubmed/20364069 http://dx.doi.org/10.3233/CLO-2010-0515 |
Ejemplares similares
-
ErbB receptors and their growth factor ligands in pediatric intestinal inflammation
por: Frey, Mark R., et al.
Publicado: (2013) -
Role of ErbB Receptors in Cancer Cell Migration and Invasion
por: Appert-Collin, Aline, et al.
Publicado: (2015) -
A monoclonal antibody targeting ErbB2 domain III inhibits ErbB2 signaling and suppresses the growth of ErbB2-overexpressing breast tumors
por: Meng, Y, et al.
Publicado: (2016) -
The Role of ErbB Receptors in Infection
por: Ho, Jemima, et al.
Publicado: (2017) -
Identification of prolidase as a high affinity ligand of the ErbB2 receptor and its regulation of ErbB2 signaling and cell growth
por: Yang, L, et al.
Publicado: (2014)